Genetic and Proteomic Data: Genetic mutations such as LRRK2, GBA, or SNCA and protein biomarkers like alpha-synuclein and tau in cerebrospinal fluid (CSF) are critical for PD. The gene discussed is MAPT; the disease is Parkinson disease.